#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fabry's disease Penile squamous cell carcinoma Malignant oligodendroglioma Endometrial cancer recurrent Haemophilia A with anti factor VIII Infantile apnoea Fms-like tyrosine kinase 3 positive T-cell lymphoma Ocular lymphoma Nephroblastoma Amyotrophic lateral sclerosis Encephalopathy neonatal Transplant rejection Heavy menstrual bleeding Hypophosphatasia More trials…

    Learn about Rare Diseases

    Cholangitis sclerosing – Life with Disease Thrombotic thrombocytopenic purpura – Basic Information Hypereosinophilic syndrome – Life with Disease Atypical teratoid/rhabdoid tumour of CNS – Diagnostics Hereditary neuropathic amyloidosis – Life with Disease Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment Advanced systemic mastocytosis – Trials in Disease Mast cell activation syndrome – Basic Information Paraneoplastic neurological syndrome Acute respiratory distress syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Indometacin Ph. Eur. Garadacimab TRIMIPRAMINE MALEATE Nizatidine Thiopental Sodium HYDROGEN PEROXIDE Pancreas Powder Pegargiminase Lysine Aspirin Defactinib Cobamamide Labetalol Hydrochloride Voclosporin Eftrenonacog Alfa SECRETIN SYNTHETIC HUMAN Rilpivirine Hydrochloride AVTX-009 Sotalol Hydrochloride Hydrocortisone HUMAN FIBROBLASTS More therapies…

    Learn about Your Condition

    Hepatorenal syndrome Herpes virus infection Micrographic skin surgery Polycystic liver disease Tympanic membrane perforation MELAS syndrome Staphylococcal infection Lung adenocarcinoma stage IV Cutaneous calcification Type V hyperlipidaemia Brain cancer metastatic Postpartum haemorrhage Infectious pleural effusion Immune-mediated myositis Heart transplant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Small cell lung cancer recurrent

  • Testing Tarlatamab in Patients with Advanced Small-Cell Lung Cancer Who Have Poor Physical Condition

    Recruiting

    2 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    • Small cell lung cancer metastatic
    Investigated Drugs:
    • Tarlatamab
    Germany

  • Study comparing GSK5764227 and topotecan in adults with relapsed small cell lung cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • GSK5764227
    • Topotecan
    Bulgaria Finland France Germany Greece Hungary +7

  • Study comparing tarlatamab with topotecan in patients with relapsed small cell lung cancer after first-line chemotherapy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Ammonium Chloride
    • Siltuximab
    • Tarlatamab
    Austria Belgium Czechia Denmark France Germany +9

  • Study of Tarlatamab Treatment for Patients with Small Cell Lung Cancer Who Have Not Responded to Two or More Previous Treatments

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Siltuximab
    • Tarlatamab
    Austria Belgium Denmark France Germany Greece +3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!